Yourgene Health PLC
LSE:YGEN
Yourgene Health PLC
LSE:YGEN
Price:
0.515 GBX
Market Closed
Updated:
May 8, 2024
Yourgene Health PLC
Cash from Financing Activities
|
Yourgene Health PLC
Cash from Financing Activities Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
CREO
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Yourgene Health PLC
LSE:YGEN
|
Cash from Financing Activities
£2.9m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
9%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Financing Activities
-$200m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Financing Activities
$63.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Financing Activities
$165.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Financing Activities
-£3.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-9%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Financing Activities
£522k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yourgene Health PLC's Cash from Financing Activities?
Cash from Financing Activities
2.9m
GBP
2.9m
GBP
Based on the financial report for Sep 30, 2022, Yourgene Health PLC's Cash from Financing Activities amounts to 2.9m GBP.
What is Yourgene Health PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
9%
9%
The average annual Cash from Financing Activities growth rates for Yourgene Health PLC have been -40% over the past three years , -17% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
